Gene · 799
CALCR: calcitonin receptor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CALCR: calcitonin receptor. Genes, record 799. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/799
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P30988 | Calcitonin receptor | 474 | 32 | Ensembl, GeneID, HGNC |
Source UniProt
Patents62
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 39517 | P30988 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 39521 | P30988 | Espacenet |
| WO 2025259600 A2 | 2025-12-18 | 14 | P30988 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 11147 | P30988 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 11605 | P30988 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 1998 | P30988 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 1999 | P30988 | Espacenet |
| KR 1020250137070 A | 2025-09-17 | 17 | P30988 | Espacenet |
| WO 2025186446 A1 | 2025-09-12 | 36 | P30988 | Espacenet |
| EP 4613860 A1 | 2025-09-10 | 36 | P30988 | Espacenet |
1 to 10 of 62
See all 62 patentsDrugs11
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action | Source |
|---|---|---|---|---|
| CALCITONIN | CHEMBL4594242 | Calcitonin receptor agonist | AGONIST | ChEMBL |
| CALCITONIN HUMAN | CHEMBL4594248 | Calcitonin receptor agonist | AGONIST | ChEMBL |
| CALCITONIN SALMON | CHEMBL3989767 | Calcitonin receptor agonist | AGONIST | ChEMBL |
| DAVALINTIDE | CHEMBL2105635 | Amylin receptor AMY1, CALCR/RAMP1 agonist | AGONIST | ChEMBL |
| PRAMLINTIDE | CHEMBL2103758 | Amylin receptor AMY2; CALCR/RAMP2 agonist | AGONIST | ChEMBL |
| PRAMLINTIDE | CHEMBL2103758 | Amylin receptor AMY1, CALCR/RAMP1 agonist | AGONIST | ChEMBL |
| PRAMLINTIDE | CHEMBL2103758 | Amylin receptor AMY3; CALCR/RAMP3 agonist | AGONIST | ChEMBL |
| PRAMLINTIDE ACETATE | CHEMBL3833353 | Amylin receptor AMY2; CALCR/RAMP2 agonist | AGONIST | ChEMBL |
| PRAMLINTIDE ACETATE | CHEMBL3833353 | Amylin receptor AMY1, CALCR/RAMP1 agonist | AGONIST | ChEMBL |
| PRAMLINTIDE ACETATE | CHEMBL3833353 | Amylin receptor AMY3; CALCR/RAMP3 agonist | AGONIST | ChEMBL |
1 to 10 of 11
See all 11 drugsTrials63
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07203248 | CALCITONIN | ClinicalTrials.gov | ||
| NCT06619015 | PRAMLINTIDE | PHASE2/PHASE3 | ClinicalTrials.gov | |
| NCT06046417 | PRAMLINTIDE | PHASE2/PHASE3 | ClinicalTrials.gov | |
| NCT05805683 | CALCITONIN | ClinicalTrials.gov | ||
| NCT05199714 | PRAMLINTIDE | ClinicalTrials.gov | ||
| NCT04816890 | PRAMLINTIDE | PHASE2 | ClinicalTrials.gov | |
| NCT04252612 | PRAMLINTIDE | EARLY_PHASE1 | ClinicalTrials.gov | |
| NCT04243629 | PRAMLINTIDE | ClinicalTrials.gov | ||
| NCT04163874 | PRAMLINTIDE | ClinicalTrials.gov | ||
| NCT04074317 | PRAMLINTIDE | PHASE2 | 2024-03-27 | ClinicalTrials.gov |
1 to 10 of 63
See all 63 trialsNIH grants1,946
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CALCR papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 12 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 6 | 2025 |
| ZIAAI001066 | International Research in Cambodia: Tropical Medicine and Vector Research | 6 | 2025 |
| K24AI134990 | Mentoring in Translational Malaria Genomics | 4 | 2025 |
| P30CA056036 | Translational Research in Cancer | 4 | 2025 |
| P50CA098252 | SPORE in Cervical Cancer | 4 | 2025 |
| R01AI124678 | Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum | 4 | 2025 |
| R01GM129325 | ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling | 4 | 2025 |
| R35GM124749 | Molecular and Cellular Mechanisms of Copper-Dependent Nutrient Signaling and Metabolism | 4 | 2025 |
1 to 10 of 1,946Source NIH's project files
See all 1,946 nih grantsPapers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-guided mapping of ototoxicity-related proteins: drug entry, damage amplification, cell death execution, and endogenous otoprotection. | Hear Res | 2026 | 42800300 | PubTator, text mining | PubMed |
| Reductant-Responsive Squalene Dual-Prodrug Nanoparticles Co-Delivering Doxorubicin and Exatecan for Synergistic Breast Tumor Therapy. | Pharmaceutics | 2026 | 42797330 | PubTator, text mining | PubMed |
| Genome-wide mapping of common and rare variant effects on adiposity across childhood. | Nat Genet | 2026 | 42791368 | PubTator, text mining | PubMed |
| Copper homeostasis in macrophages: regulatory mechanisms and immunological implications. | Front Chem | 2026 | 42769650 | PubTator, text mining | PubMed |
| Genetic and Molecular Determinants of Cancer Therapy-Related Cardiovascular Toxicity. | Cardiovasc Toxicol | 2026 | 42763821 | PubTator, text mining | PubMed |
| A dual-action humanized DKK-1 antibody that activates the Wnt/β-catenin signaling pathway and inhibits the RANKL signaling pathway for osteoporosis therapy. | Front Immunol | 2026 | 42723851 | PubTator, text mining | PubMed |
| Ethylene as a Systems-level Integrator of Plant responses to Drought and Heat stress. | J Exp Bot | 2026 | 42712210 | PubTator, text mining | PubMed |
| Metabolic-cell-death gene trio predicts survival and cuproptosis sensitivity in colorectal cancer. | J Gastrointest Oncol | 2026 | 42703393 | PubTator, text mining | PubMed |
| [64Cu]CuCl2 as a Novel Metabolic Marker of Progression and Survival in Muscle-Invasive Bladder Cancer. | Mol Imaging Biol | 2026 | 42686932 | PubTator, text mining | PubMed |
| Single-neuron connectome of nucleus accumbens. | Curr Biol | 2026 | 42679807 | PubTator, text mining | PubMed |
1 to 10 of 3,617
See all 3,617 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/799
GET https://conductscience.org/api/genes/v1/799/patents?page=2